Search Results

Keyword:Groves

Oklo Advances Construction of Groves-2 Forge Isotope Pilot Facility, Deepening Medical and Industrial Isotope Layout

Oklo Advances Construction of Groves-2 Forge Isotope Pilot Facility, Deepening Medical and Industrial Isotope Layout

Recently, U.S. nuclear technology startup Oklo announced that it will further advance the construction of the Groves-2 Forge isotope production and processing pilot facility. Located in Texas, the facility aims to build on the successful demonstration experience of the company's previous Groves Isotope Testing Reactor to comprehensively expand irradiation, processing, purification, and commercialization readiness capabilities for key isotopes. It is understood that the Groves-2 Forge facility will integrate cutting-edge hot cell processing capabilities, covering the full process chain including isotope separation, product recovery, packaging, and transportation. The facility's initial production focus will be on lutetium-177 (Lutetium-177) used for cancer radiopharmaceutical therapy and other important therapeutic isotopes...

2026-10-15

Oklo's Groves Isotope Test Reactor Achieves First Criticality, Fifth Reactor in U.S. Department of Energy Test Reactor Program Successfully Started

Oklo's Groves Isotope Test Reactor Achieves First Criticality, Fifth Reactor in U.S. Department of Energy Test Reactor Program Successfully Started

The Groves Isotope Test Reactor under Oklo, an advanced nuclear fission company in the United States, has officially achieved first criticality. The U.S. Department of Energy (DOE) confirmed that the reactor successfully reached criticality at 9:19 p.m. Eastern Time on Wednesday at the Groves site in Lockhart, Texas, becoming the fifth advanced test reactor to achieve criticality under the DOE's dedicated authorization and regulatory pathway. The Groves Isotope Test Reactor has a thermal power of 15 megawatts (MWt) and adopts an atmospheric-pressure water-cooled pool-type reactor design. It is led by Oklo Isotopes, a subsidiary of Oklo focused on medical and industrial isotope production...

2026-10-11

FSG to Provide Electrical and Control Systems Support for Oklo's Groves Isotope Test Reactor Project

FSG to Provide Electrical and Control Systems Support for Oklo's Groves Isotope Test Reactor Project

American Facility Solutions Group, LLC (FSG) announced on August 25 that it will support Oklo's Groves Isotope Test Reactor project, providing electrical, instrumentation, control, testing, and verification-related work. According to reports, the Groves Isotope Test Reactor achieved first criticality on August 5, 2026, reaching a controlled, self-sustaining nuclear chain reaction. The reactor is the fifth reactor to achieve this milestone among projects authorized under the U.S. Department of Energy's Reactor Pilot Program, and the first to reach criticality on private land under the program. The low-power test reactor is designed to lay the foundation for domestic commercial isotope production...

2026-08-26

Oklo's Groves Isotope Test Reactor Achieves First Criticality

Oklo's Groves Isotope Test Reactor Achieves First Criticality

Oklo, a U.S. advanced nuclear technology company, announced on August 6 that its Groves Isotope Test Reactor has achieved a controlled self-sustaining nuclear chain reaction at low power, reaching first criticality. This milestone comes less than a year after the project broke ground. Groves Isotope Test Reactor facility (Image: Groves) The Groves low-power test reactor, located in Lockhart, Texas, is the first reactor to achieve criticality on private land under the U.S. Department of Energy's Reactor Pilot Program. According to Oklo, the facility was built from undeveloped land, completing civil excavation, engineering construction, component fabrication or procurement, fuel configuration, and...

2026-08-07